In this article, discover how the FDA and NIH are replacing animal testing with human models, such as organoids, featuring expert insights on safer, faster and ethical drug development.

Manas Ranjan Panda is a global financial services expert with 20+ years of experience in digital transformation, regulatory compliance, and cloud migration.

Q2 2026 Earnings Conference Call August 27, 2025 5:00 PM ETCompany ParticipantsChristian Kleinerman - Executive Vice President ...

We remain broadly constructive on U.S. equities but prefer a selective and nimble approach as macro data may soften. Read more here.

This study presents a valuable application of a video-text alignment deep neural network model to improve neural encoding of naturalistic stimuli in fMRI. The authors found that models based on ...

As industries evolve towards higher levels of automation and digital intelligence, maintenance strategies are undergoing a ...

This useful study shows that stimuli of a certain size elicit theta oscillations in V1 neurons both in spikes and local field potentials, and monkeys performing a dot detection task on these stimuli ...

Following the signing of the China-US rare earth agreement, the market responded swiftly: US rare earth mining and processing ...

REFV AFMIR enhances nanoscale characterization, offering simultaneous chemical and mechanical insights with high spatial resolution and reduced lateral forces.

- In March 2025, Everest announced that the U.S. FDA has cleared its IND application for EVM14, a TAA vaccine. EVM14 is Everest's first internally developed mRNA therapeutic vaccine to receive FDA IND ...

A renewed commitment to people-centered security and the protection of fundamental rights emerged as the central outcome of the Pan-African Conference on National Security and Human Rights, which ...

Detailed price information for Crowdstrike Holdings Inc (CRWD-Q) from The Globe and Mail including charting and trades.